Biofrontera Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:BFRI) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -4.12 M-3.04 M-3.82 M-2.38 M-70 K-1.66 M -7.93 M Cash from investing activities -3 000-1 0001 0003 M-5 0000 3 M Cash from financing activities 08.5 M02.35 M—— — Free cash flow -4.12 M-3.04 M-3.82 M-2.38 M-75 K-1.66 M -7.93 M

News

Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates

BioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue Estimates

Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates

CytomX Therapeutics (CTMX) Reports Q2 Loss, Lags Revenue Estimates

Urogen Pharma (URGN) Reports Q2 Loss, Tops Revenue Estimates

Biofrontera Inc. (BFRI) Shareholder/Analyst Call Prepared Remarks Transcript

Biofrontera Inc. (BFRI) Q1 2026 Earnings Call Transcript

Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates

Humacyte, Inc. (HUMA) Reports Q1 Loss, Misses Revenue Estimates

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates

Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss

Are Medical Stocks Lagging Align Technology (ALGN) This Year?